Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 7.988.724 | 265.416 | 1 |
Institution: | Projects [No]: |
---|---|
BLUST VOLKER | 1 |
CATALYZE BV | 1 |
MC TOXICOLOGY CONSULTING | 1 |
METRIOPHARM | 1 |
METRIOPHARM DEUTSCHLAND | 1 |
Total number of partners: 5
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 5
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-08-01 | Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity | iMPact | participant | 7.988.724 | 6 |